BlueCrest Capital Management’s Aldeyra Therapeutics ALDX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-20,000	Closed	-$276K	–	826
2018 Q3	$276K	Buy	+20,000	New	+$276K	0.01%	1064
2018 Q2	–	Sell	-14,371	Closed	-$108K	–	1423
2018 Q1	$108K	Buy	+14,371	New	+$108K	﹤0.01%	1331